IL190709A - 5–אומפראזול סטרונציום או הידרט, שיטות להכנתם ותכשירי רוקחות המכילים אותם - Google Patents

5–אומפראזול סטרונציום או הידרט, שיטות להכנתם ותכשירי רוקחות המכילים אותם

Info

Publication number
IL190709A
IL190709A IL190709A IL19070908A IL190709A IL 190709 A IL190709 A IL 190709A IL 190709 A IL190709 A IL 190709A IL 19070908 A IL19070908 A IL 19070908A IL 190709 A IL190709 A IL 190709A
Authority
IL
Israel
Prior art keywords
strontium
omeprazole
hydrate
crystalline
mixture
Prior art date
Application number
IL190709A
Other languages
English (en)
Other versions
IL190709A0 (en
Original Assignee
Hanmi Holdings Co Ltd
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Holdings Co Ltd, Hanmi Pharm Ind Co Ltd filed Critical Hanmi Holdings Co Ltd
Publication of IL190709A0 publication Critical patent/IL190709A0/en
Publication of IL190709A publication Critical patent/IL190709A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL190709A 2005-10-26 2008-04-08 5–אומפראזול סטרונציום או הידרט, שיטות להכנתם ותכשירי רוקחות המכילים אותם IL190709A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20050101059 2005-10-26
KR2006000760 2006-03-06
PCT/KR2006/004369 WO2007049914A1 (en) 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Publications (2)

Publication Number Publication Date
IL190709A0 IL190709A0 (en) 2008-11-03
IL190709A true IL190709A (he) 2012-03-29

Family

ID=37967988

Family Applications (1)

Application Number Title Priority Date Filing Date
IL190709A IL190709A (he) 2005-10-26 2008-04-08 5–אומפראזול סטרונציום או הידרט, שיטות להכנתם ותכשירי רוקחות המכילים אותם

Country Status (8)

Country Link
JP (1) JP5017274B2 (he)
AU (1) AU2006306906B2 (he)
CA (1) CA2626085C (he)
IL (1) IL190709A (he)
MY (1) MY140986A (he)
NO (1) NO20082358L (he)
RU (1) RU2372345C1 (he)
WO (1) WO2007049914A1 (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
CN116102538B (zh) * 2023-01-29 2024-10-18 山东省分析测试中心 一种转晶制备三水合艾司奥美拉唑镁的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
WO2004099182A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
AU2004260832A1 (en) * 2003-07-23 2005-02-10 Nycomed Gmbh Alkaline salts of proton pump inhibitors
WO2006120520A1 (en) * 2005-05-06 2006-11-16 Glenmark Pharmaceuticals Limited Esomeprazole strontium salt, process for its preparation and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
WO2007049914A1 (en) 2007-05-03
AU2006306906B2 (en) 2010-02-04
JP5017274B2 (ja) 2012-09-05
CA2626085A1 (en) 2007-05-03
RU2372345C1 (ru) 2009-11-10
MY140986A (en) 2010-02-12
NO20082358L (no) 2008-07-25
IL190709A0 (en) 2008-11-03
AU2006306906A1 (en) 2007-05-03
JP2009513625A (ja) 2009-04-02
CA2626085C (en) 2011-12-06

Similar Documents

Publication Publication Date Title
US8586752B1 (en) Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
PL131190B1 (en) Process for preparing novel derivatives of dihydropyridine
US20060135565A1 (en) Crystalline form of rabeprazole sodium
JP4319148B2 (ja) Ｓ−（−）−アムロジピンニコチネート及びその製造方法
TW200900392A (en) Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
CA2626085C (en) S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
CA2366391C (en) Aspartate derivative of amlodipine
EP3398946A1 (en) Salt of morpholine derivative and crystalline form thereof, as well as preparation method, pharmaceutical composition and use of the same
EP1598347A1 (en) Polymorphs of pantoprazole sodium salt and process for the preparation thereof
US9034904B2 (en) Forms of dexlansoprazole and processes for the preparation thereof
KR20140018627A (ko) 알-라베프라졸, 이의 금속염의 제조방법
KR101307712B1 (ko) 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및 이를 포함하는 약학 조성물
CZ12613U1 (cs) Chemická sloučenina amlodipinaspartát a farmaceutický prostředek

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees